Shelter Pharma Ltd

Shelter Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Shelter Pharma Ltd

₹ 44.0 -0.36%
21 Jul - close price
shelter.co.in BSE - SME: 543963
About

Incorporated in 2007, Shelter Pharma Ltd manufactures pharma products including
food supplements for animals[1]

Key Points

Business Overview:[1]
SPL is a GMP & HACCP certified and ISO 9001:2015 certified manufacturer and seller of a range of herbal Ayurvedic medicines in India for humans and food supplements for animals

Website BSE
  • Market Cap ₹ 50.8 Cr.
  • Current Price ₹ 44.0
  • High / Low ₹ 69.7 / 35.7
  • Stock P/E 7.02
  • Book Value ₹ 37.0
  • Dividend Yield 0.75 %
  • ROCE 24.5 %
  • ROE 18.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 1.19 times its book value
  • Company has delivered good profit growth of 146% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 25.6%

Cons

  • Promoter holding has decreased over last quarter: -2.65%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025
17.02 19.13 19.31 20.71 24.06 26.60
13.71 14.82 15.02 16.42 19.16 21.42
Operating Profit 3.31 4.31 4.29 4.29 4.90 5.18
OPM % 19.45% 22.53% 22.22% 20.71% 20.37% 19.47%
0.00 -0.45 0.00 0.00 0.00 0.00
Interest 0.01 0.01 0.05 0.00 0.07 0.06
Depreciation 0.08 0.08 0.12 0.13 0.10 0.17
Profit before tax 3.22 3.77 4.12 4.16 4.73 4.95
Tax % 25.47% 25.46% 24.76% 25.00% 25.16% 25.05%
2.40 2.81 3.10 3.12 3.54 3.70
EPS in Rs 49.59 3.63 2.68 2.70 3.06 3.20
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2016 Mar 2017 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
28.09 29.95 30.07 22.48 30.06 36.15 39.93 50.66
27.94 30.65 29.83 22.29 27.01 28.00 31.02 40.59
Operating Profit 0.15 -0.70 0.24 0.19 3.05 8.15 8.91 10.07
OPM % 0.53% -2.34% 0.80% 0.85% 10.15% 22.54% 22.31% 19.88%
0.00 0.83 0.01 0.01 0.00 -0.97 -0.12 0.01
Interest 0.00 0.00 0.01 0.02 0.08 0.03 0.26 0.13
Depreciation 0.10 0.07 0.13 0.12 0.17 0.16 0.25 0.27
Profit before tax 0.05 0.06 0.11 0.06 2.80 6.99 8.28 9.68
Tax % 20.00% 16.67% 27.27% 33.33% 26.79% 25.46% 25.12% 25.21%
0.05 0.05 0.08 0.04 2.06 5.21 6.20 7.24
EPS in Rs 1.10 1.10 1.76 0.83 42.56 6.73 5.36 6.26
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 11%
3 Years: 19%
TTM: 27%
Compounded Profit Growth
10 Years: %
5 Years: 146%
3 Years: 52%
TTM: 15%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -19%
Return on Equity
10 Years: %
5 Years: 24%
3 Years: 26%
Last Year: 18%

Balance Sheet

Figures in Rs. Crores

Mar 2016 Mar 2017 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.45 0.45 0.45 0.48 0.48 7.74 11.56 11.56
Reserves 7.31 7.32 6.53 6.63 8.32 6.81 24.26 31.16
2.07 0.11 0.24 0.00 0.13 1.78 0.57 1.04
1.73 3.76 3.41 3.09 3.91 5.12 1.52 4.58
Total Liabilities 11.56 11.64 10.63 10.20 12.84 21.45 37.91 48.34
2.61 2.71 1.77 1.57 1.45 2.52 4.26 5.96
CWIP 0.14 0.11 0.00 0.00 0.55 0.00 0.00 0.00
Investments 0.00 0.00 0.68 0.68 0.68 0.00 0.00 0.68
8.81 8.82 8.18 7.95 10.16 18.93 33.65 41.70
Total Assets 11.56 11.64 10.63 10.20 12.84 21.45 37.91 48.34

Cash Flows

Figures in Rs. Crores

Mar 2016 Mar 2017 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.00 -0.27 -0.28 0.52 0.00 -1.85 5.48
0.00 0.29 0.03 -0.85 0.11 -4.54 -7.13
0.00 0.00 0.48 0.06 0.21 11.01 0.03
Net Cash Flow 0.00 0.02 0.23 -0.27 0.33 4.61 -1.62

Ratios

Figures in Rs. Crores

Mar 2016 Mar 2017 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 12.99 14.14 7.40 12.34 19.55 82.69 80.90 68.23
Inventory Days 61.39 49.67 55.59 69.41 80.06 110.68 125.33 127.15
Days Payable 2.49 2.16 3.35 5.35 4.52 6.54 8.96 12.32
Cash Conversion Cycle 71.89 61.65 59.64 76.40 95.09 186.84 197.26 183.06
Working Capital Days 91.35 59.59 57.05 74.85 72.49 134.69 212.07 182.57
ROCE % 0.68% 1.12% 35.91% 63.26% 32.85% 24.48%

Shareholding Pattern

Numbers in percentages

Sep 2023Mar 2024Sep 2024Mar 2025
56.89% 56.89% 54.97% 52.32%
43.11% 43.12% 45.03% 47.68%
No. of Shareholders 8368681,1191,153

Documents

Announcements

Annual reports